KINDRED BIOSCIENCES

Summary

Kindred Biosciences is a clinical-stage biopharmaceutical company focused on saving and improving the lives of pets.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 312 M

Avg. Deal Size£ 312 M

Market Context

Senior Management